Loading...
|
Please use this identifier to cite or link to this item:
http://asiair.asia.edu.tw/ir/handle/310904400/4599
|
| Title: | Synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells |
| Authors: | Konopleva, M.;Zhang, W.;Shi, Y-X.;McQueen, T.;Tsao, T.;Abdelrahim, M.;Munsell, M. F.;Johansen, M.;Yu, D.;Madden, T.;Safe, S. H.;Mien-Chie Hung;Andreeff, M. |
| Date: | 2006-02 |
| Issue Date: | 2009-11-27 05:57:00 (UTC+0) |
| Publisher: | Asia University |
| Abstract: | HER2 overexpression is one of the most recognizable molecular alterations in breast tumors known to be associated with a poor prognosis. In the study described here, we explored the effect of HER2 overexpression on the sensitivity of breast cancer cells to the growth-inhibitory effects of 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), a synthetic triterpenoid, both in vitro and in vivo in a xenograft model of breast cancer. Both cell growth and colony formation in the soft agar assay, a hallmark of the transformation phenotype, were preferentially suppressed in HER2-overexpressing cell lines at low concentrations of CDDO, whereas growth-inhibitory effects at high concentrations did not correlate with the expression level of HER2. CDDO dose-dependently inhibited phosphorylation of HER2 in HER2-overexpressing cells and diminished HER2 kinase activity in vitro. CDDO induced the transactivation of the nuclear receptor peroxisome proliferator-activated receptor-? in both vector control and HER2-transfected MCF7 cells. Dose-response studies showed that the growth inhibition seen at lower concentrations of CDDO correlated with induction of the tumor suppressor gene caveolin-1, which is known to inhibit breast cancer cell growth. CDDO also reduced cyclin D1 mRNA and protein expression. In vivo studies with liposomally encapsulated CDDO showed complete abrogation of the growth of the highly tumorigenic MCF7/HER2 cells in a xenograft model of breast cancer. These findings provide the first in vitro and in vivo evidence that CDDO effectively inhibits HER2 tyrosine kinase activity and potently suppresses the growth of HER2-overexpressing breast cancer cells and suggest that CDDO has a therapeutic potential in advanced breast cancer |
| Relation: | MOLECULAR CANCER THERAPEUTICS 5(2):317-328 |
| Appears in Collections: | [生物科技學系] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| | 0Kb | Unknown | 601 | View/Open | | 310904400-4599.doc | | 33Kb | Microsoft Word | 393 | View/Open |
|
All items in ASIAIR are protected by copyright, with all rights reserved.
|
